A Systematic Review: Ayurvedic Herbal Medicine for Women with Polycystic Ovary Syndrome †
Abstract
:1. Introduction
1.1. Types
- Insulin-resistant PCOS;
- Inflammatory PCOS;
- Post-pill PCOS;
- Hidden cause of PCOS.
1.2. Organs Involved in PCOS
- Ovary—the female gonad organ presents at either side of the uterus;
- Adrenal gland—the gland which is placed just above both of the kidneys;
- Pancreas—the gland which produces insulin in our body;
- Pituitary gland—the gland just below the brain, which is responsible for hormone control.
1.3. Symptoms of PCOS [13,14,15]
1.4. Causes of PCOS [14]
- Gene defect perturbs the biochemical pathway & leads to dysfunction of an ovary
- Contraceptive pills;
- Strong stimulation in adrenals in childhood;
- Raised insulin levels;
- Hormonal imbalance and stress.
1.5. Histological Features of PCOS
- (1)
- Whole ovarian hypertrophy, indicated with a thickened capsule (>100 µ);
- (2)
- Increased number of sub follicular cysts;
- (3)
- Scarcity of corporeal lutea or albicantia, hyperplasia, and fibrosis of the ovarian stroma [16].
1.6. COVID-19 Infection in PCOS Women
1.7. Necessity to Study PCOS
2. Genetic Propensity
2.1. Insulin Level
2.2. Excess Androgen
3. Ayurvedic Herbal Remedies Available for PCOS
- Correct the hormonal imbalance;
- Treat obesity and avoid high cholesterol levels;
- Treat insulin resistance.
3.1. Aloe [19]
3.2. Cinnamon
- Benefits of cinnamon for PCOS [27]:
- Blood sugar management;
- Menstrual cycle regulation;
- Cardiovascular health support;
- Anti-inflammatory effects.
3.3. Liquorice
- Reduced androgen levels;
- Adrenal gland support;
- Weight loss;
- Anti-inflammatory effects.
3.4. Ashwagandha
3.5. Shatavari
- Stimulates the nervous system;
- Aids in the stimulation and maintenance of hormone levels in the body.
- In the case of PCOS, we may require medications that dissolve cysts, such as Kanchnaar. However, Shatavari is an herb that helps to balance the hormones that are disrupted in PCOS, thereby maintaining hormone levels, and supports the HPO axis and plexus. Furthermore, shatavari promotes menstrual cycle duration (3 to 7 days), menstrual cycle interval (28 to 35 days), and blood flow during menstruation [30].
4. Management of PCOS [31,32,33,34]
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bulsara, J.; Patel, P.; Soni, A.; Acharya, S. A review: Brief insight into polycystic ovarian syndrome. Endocr. Metab. Sci. 2021, 3, 100085. [Google Scholar] [CrossRef]
- Knochenhauer, E.S.; Key, T.J.; Kahsar-Miller, M.; Waggoner, W.; Boots, L.R.; Azziz, R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J. Clin. Endocrinol. Metab. 1998, 83, 3078–3082. [Google Scholar] [CrossRef] [PubMed]
- Yen, S.S.; Vela, P.; Rankin, J. Inappropriate secretion of follicle stimulating hormone and luteinizing hormone in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 1970, 30, 435–477. [Google Scholar] [CrossRef] [PubMed]
- Wild, R.A.; Carmina, E.; Diamanti-Kandarakis, E.; Dokras, A.; Escobar-Morreale, H.F.; Futterweit, W.; Lobo, R.; Norman, R.J.; Talbott, E.; Dumesic, D.A. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 2010, 95, 2038–2049. [Google Scholar] [CrossRef] [PubMed]
- Ewens, K.G.; Stewart, D.R.; Ankener, W.; Urbanek, M.; McAllister, J.M.; Chen, C.; Baig, K.M.; Parker, S.C.; Margulies, E.H.; Legro, R.S.; et al. Family-based analysis of candidate genes for polycysticovary syndrome. J. Cline Endocrinal Metab. 2010, 95, 2306–2315. [Google Scholar] [CrossRef] [PubMed]
- Miller, L.G.; Murray, W.J. Herbal Medicinals: A Clinician’s Guide; Routledge: Abingdon-on-Thames, UK, 1998; p. 326. [Google Scholar]
- Tilburt, J.C.; Kaptchuk, T.J. Bulletin of the World Health Organization, 86th ed.; WHO: Geneva, Switzerland, 2008; pp. 594–599.
- Ministry of Health and Social Welfare. Zanzibar Traditional and Alternative Medicine Policy; Ministry of Health and Social Welfare: Zanzibar, Tanzania, 2008.
- Weiss, R.F. Weiss’s Herbal Medicine; Thieme: New York, NY, USA, 2001. [Google Scholar]
- Benzie, I.F.; Galor, S.W. Herbal Medicine: Biomolecular and Clinical Aspects; CRC Press: Boca Raton, FL, USA, 2011; p. 7. [Google Scholar]
- Fallon, L.F. Polycystic Ovary Syndrome, Gale Encyclopedia of Medicine, Gale Group, 3rd ed.; Solvey Publishing Co.: New York, NY, USA, 1992; pp. 223–247. [Google Scholar]
- Ndefo, U.A.; Eaton, A.; Green, M.R. Polycystic ovary syndrome: A review of treatment options with a focus on pharmacological approaches. Pharm. Ther. 2013, 38, 336–355. [Google Scholar]
- Carmina, E.; Koyama, T.; Chang, L.; Stanczyk, F.Z.; Lobo, R.A. Does ethnicity Influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome. Am. J. Obs. Gynecol. 1992, 167, 1807–1812. [Google Scholar] [CrossRef] [PubMed]
- Howkins and Bourne Shaw’s Textbook of Gynecology, 12th ed.; B.I. Churchill Livingstone Pvt. Ltd.: New Delhi, India, 1999; pp. 458–469.
- Azziz, R.; Nestler, J.E.; Dewailly, D. Androgen Excessdisorders in Women: Polycystic Ovary Syndrome and Other Disorders; Humana Press: Totowa, NJ, USA, 2006; pp. 184–196.24. [Google Scholar]
- Barnes, R.B.; Rosenfield, R.L.; Burstein, S.; Ehrmann, D.A. Pituitary-ovarian responses to Nafarelin testing in thepolycystic ovary syndrome. N. Engl. J. Med. 1989, 320, 559–565. [Google Scholar] [CrossRef] [PubMed]
- AR Androgen Receptor [Homo Sapiens (Human)]. 2018. Available online: https://www.ncbi.nlm.nih.gov/gene/367 (accessed on 22 November 2022).
- Polycystic Ovary Syndrome (PCOS). 2020. Available online: https://www.mayoclinic.org/diseases-conditions/pcos/symptomscauses/syc-20353439 (accessed on 22 November 2022).
- Gao, Y.; Kuok, K.I.; Jin, Y.; Wang, R. Biomedical Applications of Aloevera. Crit. Rev. Food Sci. Nutr. 2018, 59 (Suppl. 1), S244–S256. [Google Scholar] [CrossRef] [PubMed]
- Coats, B.C. The Silent Healer, A Modern Study of Aloe Vera; Coats: Garland, TX, USA, 1979. [Google Scholar]
- Obata, M.; Ito, S.; Beppu, H.; Fujita, K.; Nagatsu, T. Mechanisms of anti-inflammatory and anti-thermal burn action of carboxypeptidase from aloe aborescens miller. Natalensis berger in rats and mice. Physiother. Res. 1993, 7, 530–533. [Google Scholar]
- Shelton, M.S. Aloe Vera, its chemical and therapeutic properties. Int. J. Dermatol. 1991, 30, 679–683. [Google Scholar] [CrossRef] [PubMed]
- Green, P. Aloe Vera extracts in equine clinical practice. Vet. Times 1996, 26, 9. [Google Scholar]
- Lorenzetti, L.J.; Salisbury, R.; Beal, J.L. Baldwin, Bacteriostatic property of Aloe Vera. J. Pharm. Soc. 1964, 53, 1287–1290. [Google Scholar] [CrossRef] [PubMed]
- Ni, Y.; Tizard, I.R. Analytical Methodology: The Gelanalysis of Aloe Pulp and Its Derivatives; Reynolds, T., Ed.; CRC Press: Boca Raton, FL, USA, 2004; pp. 111–126. [Google Scholar]
- Joseph, B.; Raj, S.J. Pharmacognostic and phytochemical properties of Aloe vera Linn–An overview. Int. J. Pharm. Sci. Rev. Res. 2010, 4, 106–110. [Google Scholar]
- Stefanie Valakas. 3 Reasons Why You Need to Add Cinnamon to Your PCOS Diet. Available online: https://thedietologist.com.au/cinnamon-for-pcos-diet/ (accessed on 22 November 2022).
- Liquorice for PCOS: Benefits, Risks Practical Tips. Available online: https://holisticnerd.com/licorice-root-for-pcos-benefits-risks-practical-tips/ (accessed on 22 November 2022).
- 6 Ways How Ashwagandha Powder Helps PCOS. Available online: naturallyyours.in/blogs/blog/6-ways-how-ashwagandha-powder-helps-pcos (accessed on 22 November 2022).
- Alok, S.; Jain, S.K.; Verma, A.; Kumar, M.; Mahor, A.; Sabharwal, M. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review. Asian Pac. J. Trop. Dis. 2013, 3, 242–251. [Google Scholar] [CrossRef]
- Verma, A.; Dhiman, K. Management of PCOS: A Psychosomatic Disorder by Yoga Practice Systematic review of researches on Female infertility View project of PCOS: A Psychosomatic Disorder by Yoga Practice. Int. J. Innov. Res. Dev. 2015, 4, 216–219. [Google Scholar]
- Naderpoor, N.; Shorakae, S.; De Courten, B.; Misso, M.L.; Moran, L.J.; Teede, H.J. Metformin and lifestyle modification in polycysticovary syndrome: Systematic review and meta-analysis. Hum. Reprod. Update 2015, 21, 560–574. [Google Scholar] [CrossRef] [PubMed]
- Harrison, C.L.; Lombard, C.B.; Moran, L.J.; Teede, H.J. Exercise therapy in polycystic ovary syndrome: A systematic review. Hum. Reprod. Update 2011, 17, 171–183. [Google Scholar] [CrossRef] [PubMed]
- Saidunnnisa, G.; Begum, G.S.; Shariff, A.; Ayman, G.; Mohammad, B.; Housam, R.; Khaled, N. Assessment of Risk Factors for development of Polycystic Ovarian Syndrome Clinical Skills-teaching made effective View project Assessment of Risk Factors for development of Polycystic Ovarian Syndrome View Project Assessment of Risk Factors for development. Int. J. Contemp. Med. Res. 2017, 4, 2454–7379. [Google Scholar]
Compounds | Derivatives/Types |
---|---|
1. Vitamins | Vitamins A and C, thiamine, niacin, riboflavin, Vitamin B12, choline, and folic acid [20] |
2. Enzymes | Amylase, lipase, carboxypeptidase, and bradykinase [21,22] |
3. Sugar | Glucose, polysaccharides and glucomannans, pectin, hemicellulose, acemannan, and mannose derivatives [23] |
4. Phytosterols | Campesterol, sitosterol, and lupeol |
5. Anthraquinones | Anthraone-C-glycosides, chromones, and barbaloin (8-C-glucosyl-7-O-methylalordiol, 8-C-glucosyl-noreugenin, isoaloeresin D, isorabaichro-mone, and neoaloesin A) [24,25] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Dhankani, M.A.; Patil, H.J.; Dhankani, A.R. A Systematic Review: Ayurvedic Herbal Medicine for Women with Polycystic Ovary Syndrome. Med. Sci. Forum 2023, 21, 46. https://doi.org/10.3390/ECB2023-14362
Dhankani MA, Patil HJ, Dhankani AR. A Systematic Review: Ayurvedic Herbal Medicine for Women with Polycystic Ovary Syndrome. Medical Sciences Forum. 2023; 21(1):46. https://doi.org/10.3390/ECB2023-14362
Chicago/Turabian StyleDhankani, Mansi A., Harshada J. Patil, and Amitkumar R. Dhankani. 2023. "A Systematic Review: Ayurvedic Herbal Medicine for Women with Polycystic Ovary Syndrome" Medical Sciences Forum 21, no. 1: 46. https://doi.org/10.3390/ECB2023-14362
APA StyleDhankani, M. A., Patil, H. J., & Dhankani, A. R. (2023). A Systematic Review: Ayurvedic Herbal Medicine for Women with Polycystic Ovary Syndrome. Medical Sciences Forum, 21(1), 46. https://doi.org/10.3390/ECB2023-14362